JPS5315371A - Heterocyclic compound - Google Patents

Heterocyclic compound

Info

Publication number
JPS5315371A
JPS5315371A JP9132577A JP9132577A JPS5315371A JP S5315371 A JPS5315371 A JP S5315371A JP 9132577 A JP9132577 A JP 9132577A JP 9132577 A JP9132577 A JP 9132577A JP S5315371 A JPS5315371 A JP S5315371A
Authority
JP
Japan
Prior art keywords
heterocyclic compound
heterocyclic
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9132577A
Other languages
English (en)
Japanese (ja)
Inventor
Jiyon Deyuranto Gurahamu
Robin Ganerin Chiyaaron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of JPS5315371A publication Critical patent/JPS5315371A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP9132577A 1976-07-28 1977-07-28 Heterocyclic compound Pending JPS5315371A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3139376 1976-07-28

Publications (1)

Publication Number Publication Date
JPS5315371A true JPS5315371A (en) 1978-02-13

Family

ID=10322438

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9132577A Pending JPS5315371A (en) 1976-07-28 1977-07-28 Heterocyclic compound

Country Status (14)

Country Link
JP (1) JPS5315371A (pl)
AU (1) AU2734777A (pl)
BE (1) BE857219R (pl)
DE (1) DE2733952A1 (pl)
DK (1) DK331977A (pl)
ES (1) ES461101A2 (pl)
FI (1) FI772294A (pl)
FR (1) FR2359841A1 (pl)
IL (1) IL52545A0 (pl)
LU (1) LU77865A1 (pl)
NL (1) NL7708379A (pl)
NO (1) NO772669L (pl)
PL (1) PL199909A1 (pl)
ZA (1) ZA774221B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309435A (en) 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
FR2446829A1 (fr) 1978-11-16 1980-08-14 Glaxo Group Ltd Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant
JPS57102852A (en) * 1980-12-19 1982-06-26 Shionogi & Co Ltd Dicarboxylic acid diamide
ATE70261T1 (de) * 1987-09-02 1991-12-15 Ciba Geigy Ag Oligomere cyanoguanidine.
US5352831A (en) * 1987-09-02 1994-10-04 Ciba-Geigy Corporation Oligomeric cyanoguanidines
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR735087A (fr) * 1930-09-01 1932-11-03 Anticoman Ges M B H Procédé pour fabriquer des sels de polyméthylène-biguanidine se dissolvant facilement dans l'eau et dans le suc gastrique
GB1493931A (en) * 1974-02-07 1977-11-30 Smith Kline French Lab Guanidines isothioureas and thioureas

Also Published As

Publication number Publication date
IL52545A0 (en) 1977-10-31
ZA774221B (en) 1978-06-28
LU77865A1 (pl) 1977-10-24
FR2359841A1 (fr) 1978-02-24
NO772669L (no) 1978-01-31
BE857219R (fr) 1978-01-27
FI772294A (pl) 1978-01-29
ES461101A2 (es) 1978-12-01
NL7708379A (nl) 1978-01-31
DK331977A (da) 1978-01-29
DE2733952A1 (de) 1978-02-02
PL199909A1 (pl) 1978-11-20
AU2734777A (en) 1979-02-01

Similar Documents

Publication Publication Date Title
EG13149A (en) Heterocyclic compounds
JPS52151348A (en) Compound
ZA771381B (en) Heterocyclic compounds
JPS5363424A (en) Bitumious compound
JPS52151168A (en) Heterocyclic compound
JPS52125197A (en) Transshexahydroopyridooindole compound
ZA771963B (en) Heterocyclic compounds
JPS52136170A (en) Heterocyclic compound
JPS5353618A (en) Nnsubstituted biscarbamoylsulfide compound
JPS5325537A (en) Compound
JPS5359686A (en) Compound
JPS5337653A (en) 111deoxyy111oxaprostaglandin compound
JPS5295689A (en) Betaalactummcontaining compound
ZA774154B (en) Heterocyclic compounds
JPS5293772A (en) Indolinospiropyran compound
ZA777535B (en) Heterocyclic compounds
JPS5323995A (en) Antiibacterial compound
JPS5321222A (en) Bissbenzoxazolyl compound
JPS52156899A (en) Compound
JPS5315371A (en) Heterocyclic compound
JPS5315383A (en) Heterocyclic compound
JPS5353692A (en) Antiiworm compound
JPS5315370A (en) Heterocyclic compound
JPS55102588A (en) Tetraselenapentalene compound
ZA776857B (en) Heterocyclic compounds